Gout is caused by elevated levels of uric acid in the blood that crystallizes and deposits in joints, tendons, and surrounding tissues. It affects 1% of Western populations at some point in their life. 

The following research study is currently open at QUEST:

Phase III Gout

This long term study evaluates the safety and efficacy of an investigational treatment compared to allopurinol in people who have both gout and cardiovascular disease.  Participants will receive compensation for their time and travel; $50 for each completed office visit and $15 for each completed telephone call throughout the study.  There are up to 7 scheduled visits in the first year and every 6 months thereafter.  The study is expected to last approximately 5 years. Study medication, examinations and bloodwork will be provided  at no cost. 

If you or someone you care about can benefit from participating in a clinical research study, find out more by contacting us.